ViroLogic and Chiron in HIV deal

CHIR will use VLGC's PhenoSense HIV phenotypic drug resistance test to assess the activity of CHIR's non-nucleoside reverse transcriptase inhibitors (NNRTIs) against HIV strains that are resistant to ...